文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.

机构信息

University of Medicine Carol Davila, Bucuresti; Institutul de Urgente Boli Cardiovasculare C.C.Iliescu, Bucuresti, Romania.

Department of Cardiology, General Hospital Celje, Slovenia.

出版信息

Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.


DOI:10.1002/ejhf.813
PMID:28386917
Abstract

AIMS: The objectives of the present study were to describe epidemiology and outcomes in ambulatory heart failure (HF) patients stratified by left ventricular ejection fraction (LVEF) and to identify predictors for mortality at 1 year in each group. METHODS AND RESULTS: The European Society of Cardiology Heart Failure Long-Term Registry is a prospective, observational study collecting epidemiological information and 1-year follow-up data in 9134 HF patients. Patients were classified according to baseline LVEF into HF with reduced EF [EF <40% (HFrEF)], mid-range EF [EF 40-50% (HFmrEF)] and preserved EF [EF >50% (HFpEF)]. In comparison with HFpEF subjects, patients with HFrEF were younger (64 years vs. 69 years), more commonly male (78% vs. 52%), more likely to have an ischaemic aetiology (49% vs. 24%) and left bundle branch block (24% vs. 9%), but less likely to have hypertension (56% vs. 67%) or atrial fibrillation (18% vs. 32%). The HFmrEF group resembled the HFrEF group in some features, including age, gender and ischaemic aetiology, but had less left ventricular and atrial dilation. Mortality at 1 year differed significantly between HFrEF and HFpEF (8.8% vs. 6.3%); HFmrEF patients experienced intermediate rates (7.6%). Age, New York Heart Association (NYHA) class III/IV status and chronic kidney disease predicted mortality in all LVEF groups. Low systolic blood pressure and high heart rate were predictors for mortality in HFrEF and HFmrEF. A lower body mass index was independently associated with mortality in HFrEF and HFpEF patients. Atrial fibrillation predicted mortality in HFpEF patients. CONCLUSIONS: Heart failure patients stratified according to different categories of LVEF represent diverse phenotypes of demography, clinical presentation, aetiology and outcomes at 1 year. Differences in predictors for mortality might improve risk stratification and management goals.

摘要

目的:本研究旨在描述按左心室射血分数(LVEF)分层的门诊心力衰竭(HF)患者的流行病学和结局,并确定每组患者 1 年死亡率的预测因素。

方法和结果:欧洲心脏病学会心力衰竭长期注册研究是一项前瞻性、观察性研究,共纳入 9134 例 HF 患者,收集流行病学信息和 1 年随访数据。根据基线 LVEF 将患者分为射血分数降低的心力衰竭[EF<40%(HFrEF)]、中间范围射血分数[EF 40-50%(HFmrEF)]和保留射血分数[EF>50%(HFpEF)]。与 HFpEF 患者相比,HFrEF 患者更年轻(64 岁比 69 岁)、更常见为男性(78%比 52%)、更可能存在缺血性病因(49%比 24%)和左束支传导阻滞(24%比 9%),但不太可能患有高血压(56%比 67%)或心房颤动(18%比 32%)。HFmrEF 组在某些特征上与 HFrEF 组相似,包括年龄、性别和缺血性病因,但左心室和心房扩张程度较轻。HFrEF 和 HFpEF 患者 1 年死亡率差异显著(8.8%比 6.3%);HFmrEF 患者死亡率居中(7.6%)。年龄、纽约心脏协会(NYHA)心功能分级 III/IV 级和慢性肾脏病是所有 LVEF 组患者死亡的预测因素。在 HFrEF 和 HFmrEF 中,低收缩压和高心率是死亡率的预测因素。在 HFrEF 和 HFpEF 患者中,低体重指数与死亡率独立相关。心房颤动是 HFpEF 患者死亡的预测因素。

结论:根据不同 LVEF 分类分层的心力衰竭患者代表了不同的人口统计学、临床表现、病因和 1 年结局表型。死亡率预测因素的差异可能会改善风险分层和管理目标。

相似文献

[1]
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.

Eur J Heart Fail. 2017-4-6

[2]
A comprehensive population-based characterization of heart failure with mid-range ejection fraction.

Eur J Heart Fail. 2017-9-25

[3]
[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].

Zhonghua Xin Xue Guan Bing Za Zhi. 2019-11-24

[4]
Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.

Eur Heart J. 2018-12-21

[5]
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.

Clin Res Cardiol. 2017-5

[6]
Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.

Eur J Heart Fail. 2017-4-6

[7]
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.

JACC Heart Fail. 2019-3-6

[8]
Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).

BMJ Open. 2017-12-21

[9]
Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.

Heart. 2020-8

[10]
Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.

Int J Cardiol. 2018-1-28

引用本文的文献

[1]
Clinical Usefulness of Right Ventricular-Pulmonary Artery Coupling in Patients with Heart Failure.

Diagnostics (Basel). 2025-8-20

[2]
From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure.

Biomolecules. 2025-8-19

[3]
Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction.

Clin Res Cardiol. 2025-8-27

[4]
Proteomic pathways across the ejection fraction spectrum in patients with heart failure and diabetes mellitus: an EXSCEL trial substudy.

Sci Rep. 2025-8-18

[5]
Machine Learning-Driven Prediction of One-Year Readmission in HFrEF Patients: The Key Role of Inflammation.

Clin Interv Aging. 2025-7-24

[6]
Heart Failure Syndromes: Different Definitions of Different Diseases-Do We Need Separate Guidelines? A Narrative Review.

J Clin Med. 2025-7-17

[7]
Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease.

Commun Med (Lond). 2025-7-28

[8]
A predictive model for heart failure with preserved ejection fraction following acute myocardial infarction: the HFpEF-AMI score.

BMC Cardiovasc Disord. 2025-7-23

[9]
Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross-Sectional Study.

J Diabetes. 2025-7

[10]
Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease.

BMC Nephrol. 2025-7-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索